guidelines on the management of acute severe asthma emphasise the importance of systemic corticosteroids.4 Yet in this issue of Thorax two trials are reported of the use of corticosteroids in acute severe asthma that provide little evidence of any therapeutic effect.56 Can the apparent contradiction between the results of these and other trials showing no benefit for steroids in acute severe asthma and the widely held belief that they are essential be resolved? This requires an examination of our understanding of the pathogenesis of acute severe asthma, the mechanism of action of corticosteroids in asthma, and a review of published trials.
Pathophysiology of acute severe asthma
Concepts of the pathophysiology of chronic asthma have changed in the last two decades.7 Asthma is increasingly considered to be a disease of chronic airways inflammation subject to exacerbations caused by viruses, antigens, and non-specific irritants. These exacerbating factors lead to worsening of airways inflammation8 and the release of chemical mediators that cause airway smooth muscle spasm.9
These basic mechanisms are reflected in the clinical presentation of acute severe asthma. Although some attacks present as sudden wheeze and shortness of breath "out of a clear blue sky," most occur against a background of long term poorly controlled asthma or asthma that has been worsening for some days or even weeks.' The treatment of acute severe asthma is therefore an important occasion to review the management of chronic asthma as advocated in the British Thoracic Society's guidelines.4 In the management of chronic asthma the efficacy of treatment with both oral and inhaled corticosteroids is unequivocal. "l5 When we are considering the role of systemic corticosteroids in acute severe asthma treatment of the underlying chronic asthma must not be ignored. Whereas the smooth muscle spasm of acute severe asthma may respond to bronchodilators, treatment of the underlying inflammation will largely depend on the use of corticosteroids.
Mechanism of action of corticosteroids
Corticosteroids have a multitude of actions that may be potentially of benefit-in asthma. They decrease inflammatory cell recruitment and activation,'6 upregulate P2 receptors,'7 and decrease microvascular permeability'8 and they may decrease mucus production. '9 In terms of molecular mechanism steroids are thought to act by binding to a glucocorticoid receptor, which is then activated and binds to the cell nucleus, on to the regulatory glucocorticoid receptor elements associated with several genes.20 These glucocorticoid response elements then up or down regulate production of messenger RNA (mRNA), which eventually leads to increases or decreases in protein production. The proteins affected include enzymes and cell surface receptors. Such a mechanism of action, with gene regulation and then protein synthesis, will obviously take some hours or even days to show a clinical effect. In view of these basic mechanisms early effects in acute severe asthma would not be anticipated. It is customary to end a review such as this by calling for further research to be undertaken; but the weight of evidence from clinical trials of steroids in acute severe asthma, the epidemiological studies,3 and clinical experience make trials investigating the efficacy of steroid versus placebo and the route of administration difficult to justify. Unresolved questions remain-namely, the dose and the duration of treatment. The trial design used will obviously depend on the question being asked but anyone who is tempted to perform a trial of corticosteroids in acute severe asthma should bear in mind the following: (a) ideally bronchodilator treatment that is in accordance with standard practice should be used in the study; (b) if more than two treatments are compared or multiple groups are used the power of the study will decrease unless numbers are large; (c) the longer the period of observation the better, up to perhaps one week being useful; and (d) including relapse rate after discharge as an endpoint may be helpful. 
